New CEO and Chairman of the Board at Betagenon
Betagenon AB, a Sweden-based company focused on developing AMPK activator compounds, announced that James Hall BM, BCh, D.Phil has joined as CEO.
Betagenon
Chinese investment firm injects SEK 3 million USD into Umeå biotech company
Chinese investment firm Ivy Capital is investing almost 3 million USD into Umeå-based biotechnology firm Betagenon.
“This investment is incredibly important to us and the development of our product. We hope to produce a cure for widespread diseases,” says Thomas Edlund, Co-Founder and CEO of Betagenon.